Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children

Vaccine

Volumn 18, Issue 24, 2000, Pages 2704-2712

  Qadri, Firdausi ^a   Wennerås, Christine ^b   Ahmed, Firoz ^a   Asaduzzaman, Muhammad ^a   Saha, Debashish ^a   Albert, M J ^a   Sack, R B ^c   Svennerholm, Ann Mari ^b  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c NONE

Author keywords

Antibody secreting cells; Eenterotoxigenic Escherichia coli; Oral inactivated ETEC vaccine

Indexed keywords

BACTERIAL VACCINE; CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; ESCHERICHIA COLI ENTEROTOXIN;

ABDOMINAL PAIN; ADULT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BANGLADESH; BLOOD ANALYSIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG SAFETY; FECES ANALYSIS; HEADACHE; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNIZATION; MALE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; STOMACH DISTENSION;

EID: 0034213176     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00056-6     Document Type: Article

References (24)

1. Black R.E. Epidemiology of diarrheal disease: implications for control by vaccines. Vaccine. 11:1993;100-106.
2. Evans D.G., Silver R.P., Evans D.J. Jr, Chase D.G., Gorbach S.L. Plasmid-controlled colonization factor associated with virulence in Escherichia coli enterotoxigenic for humans. Infect. Immun. 12:1975;656-667.
3. Guerrant R.L. Microbial toxins and diarrhoeal disease: introduction and overview. Microbial toxins and diarrhoeal disease. Ciba Foundation Symposium 112 Pitman. London. 1985;1-13.
4. Svennerholm A.-M., Wenneras C., Holmgren J. Roles of different coli surface antigens of colonization factor antigen II in colonization by and protective immunogenicity of enterotoxigenic Escherichia coli in rabbits. Infect. Immun. 58:1990;341-346.
5. Levine M.M. Vaccines against enterotoxigenic Escherichia coli infections. Woodrow G., Levine M.M. New Generation Vaccines. New York. 1990;649-660 Dekker, New York.
6. Clemens J.D., Sack D.A., Harris J.R., et al. Cross protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trail. J. Infect. Dis. 158:1988;372-377.
7. World Health Organisation, Geneva. New frontiers in the development of vaccines against enterotoxigenic (ETEC) and enterohaemorrhagic (EHEC) E. coli infections. Weekly Epidemiological Record. 13:1999;98-100.
8. Gaastra W., Svennerholm A.M. Colonization factors of human enterotoxigenic Escherichia coli (ETEC). Trends Microbiol. 4:1996;444-452.
9. Svennerholm A.M., Åhren C., Jertborn M. Vaccines against ETEC infections. Part I: Oral inactivated vaccines against ETEC. Levine M.M., Woodrow G.C., Kaper J.B., Cobo G.S. New generation vaccines. 2nd ed. 1997;865-873 Dekker, New York.
10. Wennerås C., Svennerholm A.M., Åhren C., Czerkinsky C. Antibody-secreting cells in human peripheral blood after oral immunisation with an inactivated enterotoxigenic Escherichia coli vaccine. Infect. Immun. 60:1992;2605-2611.
11. Åhren C., Wennerås C., Holmgren J., Svennerholm A.-M. Intestinal antibody response after oral immunisation with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine. Vaccine. 11:1993;929-935.
12. Jertborn M., Christina A., Holmgren J., Svennerholm A.M. Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine. Vaccine. 16:1998;255-260.
13. Savarino S.J., Brown M., Hall E., et al. Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults. J. Infect. Dis. 177:1998;796-799.
14. Savarino S.J., Hall E.R., Basily S., et al. Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: Results of the initial evaluation in children. J. Infect. Dis. 179:1998;107-114.
15. Svennerholm A.M., Holmgren J. Identification of E. coli heat-labile enterotoxin by means of a ganglioside immunosorbent assay (GMI-ELISA) procedure. Curr. Microbiol. 1:1978;9-23.
16. Svennerholm A.-M., Wikström M., Lindblad M., Holmgren J. Monoclonal antibodies against Escherichia coli heat-stable toxin (ST) and their use in a diagnostic ST ganglioside GM1-enzyme-linked immunosorbent assay. J. Clin. Microbiol. 24:1986;585-590.
17. World Health Organization. Programme for control of diarrhoeal diseases (CDD/93.3 Rev 1). Manual for laboratory investigations of acute enteric infections. 1987;9-20 World Health Organization, Geneva.
18. Evans D.G., Evans D.J. Jr, Clegg S., Pauley J.A. Purification and characterization of the CFA/I antigen of enterotoxigenic Escherichia coli. Infect. Immun. 25:1979;738-748.
19. Klemm P., Gaastra W., McConnell M.M., Smith H.R. The CS2 fimbrial antigen from Escherichia coli, purification, characterization and partial covalent structure. FEMS Microbiol. Lett. 26:1985;207-210.
20. Sanchez J., Holmgren J. Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development. Proc. Natl. Acad. Sci. USA. 86:1989;481-485.
21. Czerkinsky C., Moldoveanu Z., Mestecky J., Nilsson LÅ, Ouchterlony Ö. A solid phase enzyme-linked immunospot assay. I. Simultaneous detection of distinct types of antibody-secreting cells. J. Immunol. Methods. 11:1988;31-37.
22. Svennerholm A.-M., Holmgren J., Black R., Levine M.M., Merson M. Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin producing Escherichia coli. J. Infect. Dis. 147:1983;514-522.
23. Ahren C., Jertborn M., Svennerholm A.-M. Intestinal immune responses to an oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin A responses in blood. Infect. Immun. 66:1998;3311-3316.
24. Kantele A., Kantele J.M., Arvilommi H., Makela P.H. Active immunity is seen as a reduction in the cell response to oral live vaccine. Vaccine. 9:1991;428-431.